J Korean Ophthalmol Soc.  1977 Dec;18(4):415-417.

A Clinical Study of Vistamycin in Ophthalmology

Affiliations
  • 1Department of Ophthalmology, School of Medicine, Seoul National University, Seoul, Korea.

Abstract

Vistamycin is a new type of aminoglycoside antibiotics and similar to Kanamycin in its antibacterial spectrum. Vistamycin is especially effective in ophthalmic field due to high penetration into the ocular tissue. In this study, the patients were divided into three groups. 1. 13 cases of ocular infectious diseases such as hordeolum and dacryocystitis. They have received intramuscular injections. 2. 32 cases receiving intramuscular injection for prophylaxis of postoperative infection. 3. 5 cases receiving topical application of 1% Vistamycin eye-drops. Group 1 and 2 were treated with intramuscular injection of Vistamycin 1.0 G.per day for 2 to 10 days. The results were summerized as follows: (1) Group 1 showed good response to Vistamycin with about 77% of efficacy rate. (2) None of group 2 developed postoperative infection. (3) The efficacy rate of group 3 was about 80%.


MeSH Terms

Anti-Bacterial Agents
Communicable Diseases
Dacryocystitis
Hordeolum
Humans
Injections, Intramuscular
Kanamycin
Ophthalmology*
Anti-Bacterial Agents
Kanamycin
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr